$29.33
0.291%
Last update: Aug 21, 2:35 PM
ACADIA Pharmaceuticals Inc Earnings Estimates
ACADNASDAQ
ACADIA Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:ACAD
ACADIA Pharmaceuticals (ACAD) is scheduled to report Q3 earnings on November 4, 2026. Analysts estimate EPS of $0.19 and quarterly revenue of $332.3M.
In the most recent quarter (Q2), ACADIA Pharmaceuticals reported EPS of $0.18, beating estimates of $0.04 by 3.5%. Revenue came in at $307.96M, exceeding the estimate of $295.22M by 0.04%.
Over the last 4 quarters, ACADIA Pharmaceuticals has averaged an EPS surprise of 1.29% and a revenue surprise of 0.03%.
Earnings Date
Nov 4
EPS Estimate
$0.190
Quarterly Revenue Estimate
$332.3M
Annual Revenue
$1.14B
as of Jun 30
ACADIA Pharmaceuticals Earnings History
Analyze the earnings history of ACADIA Pharmaceuticals using advanced sorting and filters.
ACADIA Pharmaceuticals (ACAD) Earnings Per Share
The chart below shows ACADIA Pharmaceuticals's reported EPS compared to analyst estimates over recent quarters.
ACADIA Pharmaceuticals (ACAD) Revenue
The chart below shows ACADIA Pharmaceuticals's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is ACADIA Pharmaceuticals (NASDAQ:ACAD) reporting earnings?
ACADIA Pharmaceuticals (ACAD) is scheduled to report earnings on November 4, 2026. The last reported earnings were for reported on August 4, 2026 for Q2.
What were the latest earnings per share (EPS) for ACADIA Pharmaceuticals (NASDAQ:ACAD)?
The Actual EPS was $0.18, which beat the estimate of $0.04.
What were ACADIA Pharmaceuticals’s (NASDAQ:ACAD) revenues?
The Actual Revenue was $307.96M, which beat the estimate of $295.22M.
